Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pulmonary alveolar hemorrhage
(
PAH
) is a rare and often fatal presenting feature of
systemic lupus erythematosus
(
SLE
). Reported mortality rates are extremely high, 70% to 90%. Death frequently occurs within the first several days of the hemorrhage. The hospital records of all inpatients with
PAH
and
SLE
between April 1986 and May 1991 at the Hospital of the University of Pennsylvania were reviewed. The complete resolution of
PAH
and the 75% survival rate found in this study is in marked contrast to previous reports. This experience suggests that patients with
PAH
and
SLE
may have a better prognosis than previously reported.
...
PMID:Pulmonary alveolar hemorrhage in systemic lupus erythematosus. 823 67
Pulmonary alveolar hemorrhage
(
PAH
) is a rare and often fatal presenting feature of rheumatic diseases, with high mortality rate ranging from 40% to 90%. This study was undertaken to review the clinical manifestations, disease course, prognosis, and treatment of
PAH
in rheumatic diseases in Korea. A retrospective analysis was performed from October 1995 to March 1999 at the Samsung Medical Center. Ten cases were diagnosed as having pulmonary hemorrhage with rheumatic diseases that comprised the following: 6
systemic lupus erythematosus
(
SLE
), 3 microscopic polyangiitis (MPA), and 1 mixed connective tissue disease (MCTD). In 80% of the patients in the present series,
PAH
was the first clinical manifestation of rheumatic diseases. The most consistent systemic manifestation occurring in conjunction with
PAH
was renal involvement (80%). The overall patient mortality rate was 50% (5/10) in the current series. Our study suggests that
PAH
often occurs as the first clinical manifestation of rheumatic diseases and needs urgent medical treatment including plasmapheresis in addition to cyclophosphamide and methylprednisolone.
...
PMID:Pulmonary alveolar hemorrhage in patients with rheumatic diseases in Korea. 1109 94